Welcome to our dedicated page for Futurefuel SEC filings (Ticker: FF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The FutureFuel Corp. (NYSE: FF) SEC filings page on Stock Titan provides structured access to the company’s regulatory disclosures, including Forms 10-K, 10-Q, 8-K, and proxy statements. FutureFuel is a Delaware corporation with common stock listed on the New York Stock Exchange under the symbol FF, and its filings with the U.S. Securities and Exchange Commission document its financial condition, segment performance, and corporate governance.
Through this page, investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain audited and interim financial statements, management’s discussion and analysis of the chemicals and biofuels segments, risk factor disclosures, and details on capital expenditures and projects such as backward-integrated specialty chemical capacity. Current reports on Form 8-K capture material events, including earnings releases, dividend declarations, extensions of the share repurchase program, decisions regarding biodiesel production, and changes in the composition of the board of directors.
FutureFuel’s proxy statements on Schedule 14A describe matters submitted to shareholders, such as director elections and auditor ratification, and provide additional information on governance practices. Where available, Forms 3, 4, and 5 and related ownership filings can be used to monitor insider share transactions and holdings in FF common stock.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings, helping users quickly understand segment results, major operational updates, and board or shareholder actions without reading every page. Real-time updates from EDGAR mean that new FutureFuel filings, including 10-Ks, 10-Qs, 8-Ks, and proxy materials, appear promptly on this page, giving investors a single location to analyze the company’s regulatory record and disclosure history.
FutureFuel Corp. director Ronald J. Kruszewski received a grant of stock options as part of his compensation. He was awarded 10,000 options to buy FutureFuel common stock at an exercise price of $3.7700 per share, bringing his total reported option holdings in this grant to 10,000 options.
The options were granted under the FutureFuel Corp. 2017 Omnibus Incentive Plan and are subject to its terms and an applicable option agreement. They become exercisable starting on March 18, 2026 and remain exercisable until their expiration on March 18, 2031. This is a compensation-related award, not an open-market stock purchase or sale.
FutureFuel Corp. director Rowe Richard P. received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $3.77 per share and were awarded with no cash paid at grant.
The options were granted under the FutureFuel Corp. 2017 Omnibus Incentive Plan and may be exercised from March 18, 2026 until they expire on March 18, 2031. After this grant, Rowe holds 10,000 stock options directly according to the filing.
FutureFuel Corp. director Manheim Paul received a grant of stock options, not an open-market purchase. He was awarded 10,000 stock options for FutureFuel Corp. common stock on March 18, 2026, at an exercise price of $3.77 per share. These options were granted under the company’s 2017 Omnibus Incentive Plan as compensation and may be exercised between March 18, 2026 and March 18, 2031. After this grant, his reported derivative holdings from this filing total 10,000 options.
FutureFuel Corp. director Pamela R. Butcher received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of 3.7700 per share and were issued under the FutureFuel Corp. 2017 Omnibus Incentive Plan.
The options may be exercised beginning on March 18, 2026 and remain exercisable until March 18, 2031. Following this grant, the filing shows Butcher holding 10,000 stock options directly as part of her equity-based compensation.
FutureFuel Corp. director Paul Anthony Novelly II received a grant of stock options representing 10,000 shares of common stock. The options have an exercise price of $3.77 per share and were awarded under the company’s 2017 Omnibus Incentive Plan as equity-based compensation.
The options may be exercised starting on March 18, 2026 and remain exercisable until their expiration on March 18, 2031. Following this grant, Novelly holds stock options covering 10,000 shares directly, aligning his incentives with the long-term performance of FutureFuel’s stock.
FutureFuel Corp. director Greer GBruce received a grant of stock options covering 10,000 shares of common stock. The options have an exercise price of $3.77 per share and were awarded under the company’s 2017 Omnibus Incentive Plan as compensation, not through open-market buying or selling. They may be exercised beginning on March 18, 2026 and will expire on March 18, 2031 if not used.
FutureFuel Corp. director Bedell Donald C. received a grant of 10,000 stock options as compensation. The options have an exercise price of $3.77 per share and relate to 10,000 shares of common stock. They were granted under the company’s 2017 Omnibus Incentive Plan and may be exercised from March 18, 2026 until their expiration on March 18, 2031. Following this grant, he holds 10,000 stock options directly.
FutureFuel Corp. director Dale E. Cole received a grant of stock options covering 10,000 shares of common stock. The options have a conversion price of $3.77 per share and were granted under the company’s 2017 Omnibus Incentive Plan as equity compensation.
The options may be exercised beginning on March 18, 2026 and remain exercisable until March 18, 2031. Following this award, Cole holds stock options for 10,000 underlying shares directly.
FutureFuel Corp. is a Delaware-based manufacturer of specialty chemicals and biodiesel operating from an integrated 2,200-acre site in Batesville, Arkansas. Its business is organized into two segments: Chemicals and Biofuels, with chemicals representing 62% of 2025 revenue and biofuels 38%.
The Chemicals segment combines long-term custom manufacturing, which generated 54% of total 2025 revenue, with performance chemicals at 8%. Three chemical customers accounted for 48% of total 2025 sales, highlighting meaningful customer concentration. The Biofuels segment has a demonstrated biodiesel capacity of about 59 million gallons per year but produced only 9 million gallons in 2025, down from 45 million gallons in 2024, as regulatory uncertainty constrained throughput.
The company’s results are highly sensitive to U.S. and global economic conditions, government programs such as the Renewable Fuel Standard and tax credits, and competition from renewable diesel and imports. It emphasizes environmental stewardship, spending $7,862 on environmental protection in 2025, and maintains robust cybersecurity and human capital programs while outlining extensive risk factors ranging from regulation and feedstock availability to technology change and cyber-incidents.
FutureFuel Corp. reported sharply weaker results for 2025, swinging to a net loss of $49.4 million or $1.13 per diluted share from net income of $15.5 million in 2024. Revenue fell to $95.7 million from $243.3 million as biofuel sales dropped amid clean fuel credit uncertainty and high input costs.
Adjusted EBITDA declined to ($38.3) million from $21.3 million, reflecting losses in both chemicals and biofuels. Cash and cash equivalents decreased to $51.3 million as of December 31, 2025 from $109.5 million a year earlier, while capital expenditures rose to $17.2 million, including a new methacrylate plant expected to contribute meaningfully from 2026. The company declared a $0.06 per-share cash dividend for the first quarter of 2026.